# Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy

> **NCT05727735** · NA · COMPLETED · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 56 (actual)

## Conditions studied

- Lung Cancer
- Thoracic Cancer
- Lung Neoplasm

## Interventions

- **DEVICE:** Medtronic Signia Stapler
- **DRUG:** Da Vinci Vessel Sealer Extend Energy Device with SureForm Stapling

## Key facts

- **NCT ID:** NCT05727735
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-14
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727735, "Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05727735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*